Phase 0/1 Biomarker and Pharmacodynamic Study of Roflumilast in Patients With Advanced B-Cell Hematologic Malignancies (CTRC# 13-0013)

Press/Media: Press / Media

PeriodOct 2 2018

Media coverage

1

Media coverage

  • TitlePhase 0/1 Biomarker and Pharmacodynamic Study of Roflumilast in Patients With Advanced B-Cell Hematologic Malignancies (CTRC# 13-0013)
    Media name/outletClinical Trials.gov
    CountryUnited States
    Date10/2/18
    PersonsRicardo C Aguiar, Anand B Karnad